Risk of adverse events after Omicron XBB-adapted BNT162b2 COVID-19 vaccination in the United States

2019-20 coronavirus outbreak Betacoronavirus Pandemic Coronavirus Infections
DOI: 10.1016/j.vaccine.2024.126629 Publication Date: 2024-12-18T20:14:46Z